Image Sourced ShutterStock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Medical solutions company Neurotech has launched its pilot-test model for Mente Clinic, a website and mobile application based virtual clinic
  • The software, focused on bringing health services to rural users, allows for clients to book appointments online, video call their practitioners and to be monitored remotely
  • Early users will be receiving discounts on the subscription model for the software that is now available through web browsers, Android and iOS

Medical device company Neurotech International surged 150 per cent this morning after announcing a brand new virtual clinic model.

Mente Clinic, which is currently in a ‘pilot stage’, allows for medical clinicians to remotely monitor and interact with their patients. The digital clinic is accessible through online browsers, iOS and Android app stores.

Clients using video conferencing and instant messaging to organise appointments is just one of the many assets offered on the platform.

Company management outlined in its media release that the core function of Mente Clinic is to extend the reach of practitioners and to service patients living in remote areas.

Since the application is currently in a pilot-test, Neurotech has launched the ‘Early Adopters’ Program. Early Adopter users will receive discounts on the Mente Clinic subscription service.

Neurotech CEO Peter Griffiths expressed excitement for the Early Adopters Program and the feedback that will be gained throughout the app’s pilot test.

“We want our Early Adopters to play a leading role as we work to expand the reach of Mente. Through their participation in this program, they can benefit from introductory pricing and help us by providing ongoing feedback on Mente and its benefits,” he said.

Earlier this year in April, Neurotech reported quarterly net cash at $432,000. This current quarter, which is still unreported on, was estimated for a cash outflow of $375,000 in the same report.

Shares in NTI are currently trading at a price of 3.5 cents in a $1.9 million market cap.

NTI by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.